Literature DB >> 11674843

Designing immune responses with genetic immunization and immunostimulatory DNA sequences.

J Thalhamer1, W Leitner, P Hammerl, J Brtko.   

Abstract

Genetic immunization or DNA vaccination represents a rapidly developing technology with new perspectives for the prevention and therapy of infectious diseases and it offers new approaches for the treatment of autoimmunity, tumors and even allergy. DNA vaccines are comprised of plasmid DNA which encodes antigen molecules directly in the transfected cells of a target organism. In contrast to protein-induced immune responses, DNA vaccines stimulate both humoral and cell-mediated immune reactions. In the present review we present a palette of unique features of genetic immunization like the effect of CpG motifs, the influence of mode and site of gene delivery and the modulation of immune responses by co-delivery of cytokines, colony stimulating factors, adhesion molecules and other stimulatory molecules. In addition, modulation of the immune response via translation, processing and presentation will be discussed, which in sum demonstrate the elegant possibilities of genetic immunization to induce tailor-made immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11674843

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  2 in total

1.  Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection.

Authors:  Diane Rottembourg; Christophe M Filippi; Damien Bresson; Katrin Ehrhardt; Elizabeth A Estes; Janine E Oldham; Matthias G von Herrath
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

2.  Human dendritic cells transfected with allergen-DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitro.

Authors:  Bettina König; Arnd Petersen; Iris Bellinghausen; Ingo Böttcher; Wolf-Meinhard Becker; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2007-10       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.